rs587783633

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BS2BP4BA1

This summary comes from the ClinGen Evidence Repository: The highest population minor allele frequency of the p.Gln70Pro variant in FOXG1 in gnomAD v4.1 is 0.00033 in the Admixed American population, which is higher than the ClinGen Rett and Angelman-like Disorders VCEP threshold (≥0.0003) for BA1, and therefore meets this criterion (BA1). The p.Gln70Pro variant is observed in at least 2 unaffected individuals (Internal database - Ambry) (BS2). Computational analysis prediction tools suggest that the p.Gln70Pro variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Gln70Pro variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BS2, BP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA294776/MONDO:0100040/035

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

FOXG1
NM_005249.5 missense

Scores

1
18

Clinical Significance

Benign reviewed by expert panel U:1B:5

Conservation

PhyloP100: 0.693
Variant links:
Genes affected
FOXG1 (HGNC:3811): (forkhead box G1) This locus encodes a member of the fork-head transcription factor family. The encoded protein, which functions as a transcriptional repressor, is highly expressed in neural tissues during brain development. Mutations at this locus have been associated with Rett syndrome and a diverse spectrum of neurodevelopmental disorders defined as part of the FOXG1 syndrome. This gene is disregulated in many types of cancer and is the target of multiple microRNAs that regulate the proliferation of tumor cells. [provided by RefSeq, Jul 2020]
LINC01551 (HGNC:19828): (long intergenic non-protein coding RNA 1551)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FOXG1NM_005249.5 linkuse as main transcriptc.209A>C p.Gln70Pro missense_variant 1/1 ENST00000313071.7 NP_005240.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FOXG1ENST00000313071.7 linkuse as main transcriptc.209A>C p.Gln70Pro missense_variant 1/1 NM_005249.5 ENSP00000339004 P1
FOXG1ENST00000706482.1 linkuse as main transcriptc.209A>C p.Gln70Pro missense_variant 2/2 ENSP00000516406 P1
LINC01551ENST00000675861.1 linkuse as main transcriptn.374+1475A>C intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.000272
AC:
38
AN:
139852
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000781
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000773
Gnomad ASJ
AF:
0.000307
Gnomad EAS
AF:
0.000846
Gnomad SAS
AF:
0.000224
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00370
Gnomad NFE
AF:
0.000219
Gnomad OTH
AF:
0.00157
GnomAD3 exomes
AF:
0.000138
AC:
5
AN:
36220
Hom.:
0
AF XY:
0.000178
AC XY:
4
AN XY:
22444
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000348
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000127
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000151
AC:
132
AN:
871366
Hom.:
0
Cov.:
16
AF XY:
0.000141
AC XY:
59
AN XY:
418988
show subpopulations
Gnomad4 AFR exome
AF:
0.000304
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000950
Gnomad4 SAS exome
AF:
0.000195
Gnomad4 FIN exome
AF:
0.0000827
Gnomad4 NFE exome
AF:
0.000152
Gnomad4 OTH exome
AF:
0.000164
GnomAD4 genome
AF:
0.000264
AC:
37
AN:
139948
Hom.:
0
Cov.:
31
AF XY:
0.000206
AC XY:
14
AN XY:
68106
show subpopulations
Gnomad4 AFR
AF:
0.0000779
Gnomad4 AMR
AF:
0.000772
Gnomad4 ASJ
AF:
0.000307
Gnomad4 EAS
AF:
0.000849
Gnomad4 SAS
AF:
0.000224
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000219
Gnomad4 OTH
AF:
0.00155
Alfa
AF:
0.000253
Hom.:
0
Bravo
AF:
0.000366
ExAC
AF:
0.0000714
AC:
2

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:5
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Rett syndrome, congenital variant Uncertain:1Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 24, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityMar 17, 2021- -
not specified Benign:2
Likely benign, criteria provided, single submitterclinical testingGeneDxDec 01, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoFeb 08, 2013- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 06, 2017This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
FOXG1 disorder Benign:1
Benign, reviewed by expert panelcurationClinGen Rett and Angelman-like Disorders Variant Curation Expert PanelJun 25, 2024The highest population minor allele frequency of the p.Gln70Pro variant in FOXG1 in gnomAD v4.1 is 0.00033 in the Admixed American population, which is higher than the ClinGen Rett and Angelman-like Disorders VCEP threshold (≥0.0003) for BA1, and therefore meets this criterion (BA1). The p.Gln70Pro variant is observed in at least 2 unaffected individuals (Internal database - Ambry) (BS2). Computational analysis prediction tools suggest that the p.Gln70Pro variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Gln70Pro variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BS2, BP4). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
16
DANN
Benign
0.78
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.049
N
LIST_S2
Benign
0.35
T
M_CAP
Benign
0.074
D
MetaRNN
Benign
0.071
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.69
N
MutationTaster
Benign
1.0
N;N
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-0.37
N
REVEL
Benign
0.035
Sift
Benign
0.35
T
Sift4G
Benign
0.29
T
Polyphen
0.80
P
Vest4
0.33
MutPred
0.32
Gain of catalytic residue at P65 (P = 5e-04);
MVP
0.040
ClinPred
0.041
T
GERP RS
0.93
Varity_R
0.089
gMVP
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs587783633; hg19: chr14-29236694; API